4th ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers
15 ESCO credits
29.11.2019 - 01.12.2019
Milan, Italy
COURSES AND SEMINARS
Rare brain cancers, Rare cancers, Rare endocrine cancers, Rare gastro-intestinal cancers, Rare genito-urinary cancers, Rare gynaecological cancers, Rare head and neck cancers, Rare skin/eye melanoma, Rare thoracic cancers, Sarcoma
Description
Chairs: Massimo Conio, IT – Peter D. Siersema, NL
The last five years, gastrointestinal endoscopy has seen an impressive progress in diagnosing and treating premalignant and early malignancy but also palliating malignancy at a stage when cure is no longer possible. The aim of this advanced course is to provide an update by experts in the respective fields.
The advanced course is specifically addressed to junior specialists and each topic will be analyzed in a systematic and propaedeutic way, from basic to the most complex and difficult procedures. The advanced course will consist of a series of focused presentations, update lectures and video sessions. Presenters will be using case illustrative examples and high-quality video throughout the programme. In addition, live endoscopy cases will be demonstrated.
We aim to for high level interaction between the faculty and the participants throughout the course and clinical case discussions in groups will be scheduled each day where the participants’ clinical cases will be discussed. The importance of the multidisciplinary approach to gastrointestinal cancers will be highlighted.
Together with gastroenterologists, interventional radiologists, surgeons and oncologists, participants will be actively involved both in the presentations and in the discussions.
The key aim of the course is to illustrate that gastrointestinal endoscopy may offer its best potential particularly when it is part of a comprehensive clinical evaluation of the patient.
LEARNING OBJECTIVES
• Update on epidemiology of gastrointestinal cancers and precancerous conditions/lesions.
• Appraise the role of endoscopy in several scenarios.
• Discuss cancer genetics and the role of endoscopy.
• Update on endoscopic diagnostic approaches and endotherapy in a multidisciplinary perspective.
• Update on technological innovations.
• Discuss indications and limits of endoscopy and methods to acquire competency in endoscopy.
• Competency in endoscopy but also in clinical research: how to prepare a research protocol.
Information
TEACHING FORMAT
The advanced course offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines, which will be concluded in take-home messages.
Participants will deliver case presentations and discuss these with the chairs and the faculty.
Admitted participants will be requested to take part in the whole event. The advanced course will be entirely in English and fluency in English is necessary for admission.
THE ADVANCED COURSE:
- Is a 4-day, educational and practical event
- Presents full covering of premalignant lesions and malignancies of the gastrointestinal tract
- Is clinically and multi-disciplinary-oriented
- Includes a broad international faculty of top experts delivering lectures and holding interactions focusing on the management of esophageal, gastric, hepatobiliary, pancreatic and colon cancer
- Provides active interaction with other junior specialists from various countries and the experts
- Is located at the renowned teaching university hospital, Erasmus MC University Medical Center Rotterdam
ACCREDITATION
Participants will be issued a certificate of attendance. An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be sent by email.
Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE). The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
ESCO - The ESO College
Being selected to take part in this ESO activity gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
This event also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the event earns participants 18 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.
LANGUAGE
The advanced course will be held in English and translation will not be provided.
INSURANCE
The organizers bear no responsibility for untoward events in relation to the participation in the Conference. Participants are advised to take out their own personal and travel insurance coverage.
Should you have any queries, please do not hesitate to contact the event organiser:
Should you have any queries, please do not hesitate to contact the event organiser:
Sonia Bulgarelli – sbulgarelli@eso.net
Elena Fiore – efiore@eso.net
Programme
20 September | ||
| 13:30 | Registration | |
| 14:30 | Welcome Riccardo A. Audisio, SE - Massimo Conio, IT - Peter Siersema, NL | |
| 14:35 | ESOPHAGUS | |
| 14:35 | Screening and Surveillance of squamous cell cancer Arjun Koch, NL | |
| 14:55 | Live Endoscopy (from the Endoscopy Unit of the Erasmus MC – Rotterdam) | |
| 15:40 | When to perform esophageal resection or ablation for Barrett’s esophagus? Alanna Ebigdo, DE | |
| 16:10 | Coffee break | |
| 16:30 | ESOPHAGUS | |
| 16:30 | Early esophageal cancer – EMR or ESD? Rehan Haidry, UK | |
| 16:50 | Screening and Surveillance of Barrett’s esophagus Manon Spaander, NL | |
| 17:10 | Update lecture: Barrett’s esophagus – role of artificial intelligence Alanna Ebigdo, DE | |
| 17:30 | Palliation of Esophageal cancer Peter Siersema, NL | |
| 17:45 | Discussion | |
| 18:00 | Clinical case presentation | |
| 18:45 | End of the day | |
21 September | ||
| 9:00 | STOMACH | |
| 9:00 | Screening and Surveillance of atrophic gastritis, intestinal metaplasia Judith Honing, NL | |
| 9:15 | Diagnosis and treatment of early gastric cancer Diogo Libanio, PT | |
| 9:35 | Diagnosis and endoscopic treatment of submucosal tumors Rita Conigliaro, IT | |
| 9:55 | Endoscopic treatment of gastric outlet obstruction Peter Siersema, NL | |
| 10:10 | Discussion | |
| 10:25 | Clinical case presentation | |
| 11:10 | Coffee break | |
| 11:30 | STOMACH + OTHER | |
| 11:30 | Missing upper gastrointestinal cancer at endoscopy – How often and how to prevent? Nigel Trudgill, UK | |
| 11:50 | Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants Andrei Voiosu, NL | |
| 12:10 | New hemostatic therapies – Sprays, gels, clips, OTSCs Kirill Basiliya, NL | |
| 12:30 | Clinical case presentation | |
| 13:15 | Lunch | |
| 14:15 | PANCREATICOBILIARY | |
| 14:15 | The role of EUS-guided interventions in pancreaticobiliary malignancies Raffaele Manta, IT | |
| 14:45 | Tips and tricks for a successful ERCP cannulation in pancreaticobiliary malignancies Massimiliano Mutignani, IT | |
| 15:05 | Management of hilar cholangiocarcinoma Massimiliano Mutignani, IT | |
| 15:25 | Clinical case presentation | |
| 16:10 | Coffee break | |
| 16:30 | PANCREATICOBILIARY + SMALL BOWEL | |
| 16:30 | Malignant potential of pancreatic cysts - when to operate Iris Levink, NL | |
| 16:50 | The multidisciplinary approach for pancreatic cancer and cholangiocarcinoma Massimiliano Mutignani, IT | |
| 17:10 | Resection of duodenal ampullary tumors: when endoscoppy, when surgery? Kirill Basiliya, NL | |
| 17:30 | Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel tumors Marco Pennazio, IT | |
| 17:50 | Discussion | |
| 18:10 | End of the day | |
22 September | ||
| 8:40 | PANCREATICOBILIARY + SMALL BOWEL | |
| 8:40 | Superficial non-ampullary duodenal epithelial tumors (SNADETs): surveillance or endoscopic treatment? Tanya Bisseling, NL | |
| 9:00 | COLON | |
| 9:00 | Surveillance for colorectal cancer – what is the future? Nastazja Pilonis, NL | |
| 9:20 | Computer-assisted systems (CADe/CADx) for detection and characterization of colorectal neoplasia – hype of here to stay? Michiel Maas, NL | |
| 9:40 | Why is it important to differentiate between adenomatous and serrated polyps, or is it not? David Tate, BE | |
| 10:00 | Tips and tricks for performing polypectomy – hot snare, cold snare, underwater, etc. David Tate, BE | |
| 10:20 | Clinical case presentation | |
| 10:50 | Coffee break | |
| 11:10 | COLON | |
| 11:10 | Challenges in T1 colorectal cancer Marco Allaix, IT | |
| 11:30 | How to treat (obstructing) colorectal cancer – Stent or surgery? Marco Allaix, IT | |
| 11:50 | Colonoscopic surveillance in inflammatory bowel disease Lauranne Derikx, NL | |
| 12:10 | Discussion | |
| 12:30 | Closing remarks and departures | |
Faculty
Marco Allaix, University of Torino, Italy
Riccardo A. Audisio, Trieste, IT
Kirill Basiliya, Leids Universitair Medisch Centrum | LUMC, NL
Tanya Bisseling, Radboudumc, NL
Rita Conigliaro, Nuovo Ospedale Civile - S. Agostino Estense, Unità di Endoscopia Digestiva, Modena, IT
Massimo Conio, Santa Corona & San Paolo General Hospitals, Gastroenterology Dpt., Pietra Ligure, IT
Lauranne Derikx, Radboudumc, Gastroenterology And Hepatology Dept., Nijmegen, NL
Alanna Ebigdo, Klinikum Augsburg, DE
Rehan Haidry, Cleveland Clinic London, Consultant Gastroenterologist, London, UK
Judith Honing, Erasmus University Medical Center, Gastro-enterology Dpt., Rotterdam, NL
Arjun Koch, Erasmus University Medical Center, Gastrointestinal Cancers Dpt., Rotterdam, NL
Iris Levink, Erasmus MC, ., Rotterdam, NL
Diogo Libanio, Portuguese Oncology Institute of Porto, PT
Michiel Maas, Radboudumc, NL
Raffaele Manta, Potenza, IT
Massimiliano Mutignani, Niguarda Hospital, Surgical Department, Milan, IT
Marco Pennazio, City of Health and Science University Hospital, Division of Gastroenterology, Torino, IT
Nastazja Pilonis, Clinical Effectiveness Research Group, University of Oslo, NL
Peter Siersema, Erasmus University Medical Center, Dept. of Gastroenterology and Hepatology, Rotterdam, NL
Manon Spaander, Erasmus Medical Center, Gastroenterology & Hepatology Dept., Rotterdam, NL
David Tate, University Hospital of Ghent, Endoscopy Dpt., Ghent, BE
Nigel Trudgill, NHS Sandwell and West Birmingham, Gastrointestinal cancer and therapeutic endoscopy Dpt., Birmingham, UK
Andrei Voiosu, NL
Application
APPLICATION CLOSED
PARTICIPATION
Attendance is limited to 50 participants and admittance is by competitive application only.
Successful applicants are required to pay a fee of EUR 200, which covers:
- Access to the course and its educational resources
- Accommodation for 2 nights in Rotterdam
- Meals according to the programme
A fee of EUR 100 is foreseen for those not requiring accommodation.
The fee does not cover travel costs, these should be organized and paid by the participant.
A discount of 100 EUR is given to participants who are already ESCO members.
The registration fee for this event is a small contribution towards the cost for organising it, therefore it will not be refunded if a participant withdraws or is unable to attend, for whatever reason.
IDEAL PROFILE OF THE ADVANCED COURSE CANDIDATE
• Young specialists (45 years or younger) in gastroenterology and endoscopy
• Interest in clinical research
• Fluency in English
HOW TO APPLY
Interested oncologists should apply online (at the top of this page) providing:
- Supporting letter from senior physician or mentor;
- CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
- Clinical case (optional - please, use this template)
ATTENDANCE TO THE ADVANCED COURSE IS BY APPLICATION ONLY.